In Vitro and In Vivo Biological Evaluation of Novel 1,4‐Naphthoquinone Derivatives as Potential Anticancer Agents
ChemMedChem · 2024
DOI: 10.1002/cmdc.202400495 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Palanisamy Ravichandiran und 7 weiteren Autor:innen. Beteiligte Einrichtung: R&D Education Center for Whole Life Cycle R&D of Fuel Cell Systems, Jeonbuk National University, Jeonju, Jeollabuk-do, 54896, Republic of Korea. Hauptthemen laut MEDLINE: Naphthoquinones, Antineoplastic Agents, Zebrafish, Apoptosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Polish National Science Centre research.
Abstract (Originalsprache)
A novel library of naphthoquinone derivatives ( 3–5 aa ) was synthesized and evaluated for their anticancer properties. Specifically, compounds 5 i, 5 l, 5 o, 5 q, 5 r, 5 s, 5 t , and 5 v demonstrated superior cytotoxic activity against the cancer cell lines that were studied. All the studied compounds exhibited a higher selectivity index (SI) and a favourable safety profile than the standard drug doxorubicin. Notably, compound 5 v displayed a greater cytotoxic effect on MCF‐7 cells (IC 50 =1.2 μM, and 0.9 μM at 24 h and 48 h, respectively) compared to the standard drug doxorubicin (IC 50 =2.4 μM, and 2.1 μM at 24 h and 48 h, respectively). To further investigate the mechanism of cytotoxic effect, additional anticancer studies were conducted with 5 v in MCF‐7 cells. The studies are including morphological changes, AO/EB (acridine orange/ethidium bromide) double staining, apoptosis analysis, cell colony assay, SDS‐PAGE and Western blotting, cell cycle analysis, and detecting reactive oxygen species (ROS) assay. The findings showed that 5 v triggered cytotoxic effects in MCF‐7 cells through the initiation of cell cycle arrest at the G1/S phase and necrosis. In vivo ecotoxicity studies indicated that 5 v had lower toxicity towards zebrafish larvae (LC 50 =50.15 μM) and had an insignificant impact on cardiac functions. In vivo xenotransplantation of MCF‐7 cells in zebrafish larvae demonstrated a significant reduction in tumour volume in the xenograft. Approximately 95 % of the zebrafish larvae with 5 v xenografts survived after 10 days of the treatment. Finally, a computational modelling study was conducted on four protein receptors, namely ER, EFGR, BRCA1, and VEFGR2. The findings highlight the importance of the aminonaphthoquinone moiety, amide linkage, and propyl thio moiety in enhancing the anticancer properties. 5 v exhibited superior drug‐likeness features and docking scores (−9.1, −7.1, −8.9, and −10.9 kcal/mol) compared to doxorubicin (−7.2, −6.1, −6.9, and −7.3 kcal/mol) against ER, EFGR, BRCA1, and VEGFR2 receptors, respectively. Therefore, the notable antitumor effects of naphthoquinone derivatives ( 3–5 aa ) suggest that these molecular frameworks may play a role in the development of promising anticancer agents for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- R&D Education Center for Whole Life Cycle R&D of Fuel Cell Systems, Jeonbuk National University, Jeonju, Jeollabuk-do, 54896, Republic of Korea.
- Department of Life Science, Department of Energy Storage/Conversion Engineering of Graduate School, Hydrogen and Fuel Cell Research Center, Jeonbuk National University, Jeonju, Jeollabuk-do, 54896, Republic of Korea.
- Present Address: Analytical, HP Green R & D Centre, Hindustan Petroleum Corporation Limited, KIADB Industrial Area, Devangundi, Hoskote, Bengaluru, Karnataka, 562114, India.
- Department of Molecular Biology, Institute of Biological Sciences, The John Paul II Catholic University of Lublin, ul. Konstantynów 1i, 20-708, Lublin, Poland.
- Department of Physics and Astronomy, University of Delaware, Newark, DE, 19716, USA.
- Department of Medical Chemistry, Medical University of Lublin, Ul. Chodźki 4 A, 20-093, Lublin, Poland.
ORCID-Profile: Palanisamy Ravichandiran, Aleksandra Martyna, Elżbieta Kochanowicz, Konrad Kubiński, Maciej Masłyk, Anna Boguszewska-Czubara
Förderung
- Polish National Science Centre research
Zitieren
APA
Ravichandiran, P., Martyna, A., Kochanowicz, E., Maroli, N., Kubiński, K., Masłyk, M., Boguszewska-Czubara, A., & Ramesh, T. (2024). In Vitro and In Vivo Biological Evaluation of Novel 1,4‐Naphthoquinone Derivatives as Potential Anticancer Agents. ChemMedChem. https://doi.org/10.1002/cmdc.202400495
Vancouver
Ravichandiran P, Martyna A, Kochanowicz E, Maroli N, Kubiński K, Masłyk M, et al. In Vitro and In Vivo Biological Evaluation of Novel 1,4‐Naphthoquinone Derivatives as Potential Anticancer Agents. ChemMedChem. 2024. doi:10.1002/cmdc.202400495
BibTeX
@article{Ravichandiran2024,
author = {Ravichandiran, Palanisamy and Martyna, Aleksandra and Kochanowicz, Elżbieta and Maroli, Nikhil and Kubiński, Konrad and Masłyk, Maciej and Boguszewska-Czubara, Anna and Ramesh, Thiyagarajan},
title = {In Vitro and In Vivo Biological Evaluation of Novel 1,4‐Naphthoquinone Derivatives as Potential Anticancer Agents},
journal = {ChemMedChem},
year = {2024},
doi = {10.1002/cmdc.202400495}
}
EUVIMED